Home

Frazier Healthcare V, LP

CIK 1341169 · last filed 2016-11-03

Frazier Healthcare V, LP is a corporate insider who has filed 6 SEC Form 4 insider transactions across 3 companies since 2008. Across all open-market trades the lifetime net is +$4.1M, making them a net buyer over the disclosed history. The firm reports its address in Seattle, WA. 61 SEC filings were submitted jointly with FHM V, LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

6

Lifetime Open-Market Net

$4.12M

Filer Profile

Reported Address
601 UNION STREET, SUITE 3200
SEATTLE, WA 98101
Phone
(206) 621-7200
State of Incorporation
DE
Related Filers
FHM V, LP — 61 joint filings, latest 2018-05-15
FHM V, LLC — 59 joint filings, latest 2018-05-15
FHM IV LP — 40 joint filings, latest 2008-03-10
FRAZIER AFFILIATES IV LP — 40 joint filings, latest 2008-03-10
FRAZIER HEALTHCARE IV LP — 40 joint filings, latest 2008-03-10
ANAPTYSBIO, INC — 9 joint filings, latest 2020-11-18
Nathan R Every — 7 joint filings, latest 2018-05-15
ALAN D FRAZIER — 7 joint filings, latest 2018-05-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Tobira Therapeutics, Inc. (TBRA) Delisted 10%+ Owner 2,668,570 — — $0 1 2015-05-06
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted 10%+ Owner 117,454 $6.22 $730.6K $1.96M 1 2009-02-12
AMICUS THERAPEUTICS, INC. (FOLD) Delisted 10%+ Owner 830,718 $14.49 $12.04M $2.16M 3 2008-03-05

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2016-11-03 — U −2,668,570 -$75.65M
2015-05-06 Tobira Therapeutics, Inc. (TBRA) Delisted Grant (A) +2,668,570 $0 EDGAR
2009-02-12 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Buy (P) +1,039,378 $1.96M EDGAR
2008-03-05 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Buy (P) +137,556 $1.36M EDGAR
2008-02-25 AMICUS THERAPEUTICS, INC. (FOLD) Delisted — — $0 EDGAR
2008-02-04 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Buy (P) +81,600 $799.2K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.